Lenalidomide
NDC Package 82293-006-10
Package Information
Lenalidomide is capsules in combination with dexamethasone is indicated for the treatment of adult patients with multiple myeloma (MM).Lenalidomide capsules are indicated as maintenance therapy in adult patients with MM following autologous hematopoietic stem cell transplantation (auto-HSCT). Marketed by Novugen Pharma (usa) Llc, this product is identified by NDC 82293-006 and is authorized under FDA application ANDA217281.
Identification & Billing
- RxCUI: 1242231 - lenalidomide 2.5 MG Oral Capsule
- RxCUI: 1428947 - lenalidomide 20 MG Oral Capsule
- RxCUI: 602910 - lenalidomide 10 MG Oral Capsule
- RxCUI: 602912 - lenalidomide 5 MG Oral Capsule
- RxCUI: 643712 - lenalidomide 15 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 82293 - Novugen Pharma (usa) Llc
- 82293-006 - Lenalidomide
- 82293-006-10 - 28 CAPSULE in 1 BOTTLE
- 82293-006 - Lenalidomide
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 82293-006-10 identifies a specific commercial package of 28 capsule in 1 bottle of Lenalidomide, labeled by Novugen Pharma (usa) Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 28 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Novugen Pharma (usa) Llc on January 06, 2026. The current certification is valid through October 23, 2026.
How is this Novugen Pharma (usa) Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 82293000610. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 28 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.